Homo- and heteroleptic bis-tridentate ruthenium(II) and osmium(II) complexes of compositions [(tpy-PhCH(3))Ru(tpy-HImzPh(3))](ClO(4))(2) (1), [(H(2)pbbzim)Ru(tpy-HImzPh(3))] (ClO(4))(2) (2) and [M(tpy-HImzPh(3))(2)](ClO(4))(2) [M = Ru(II) (3) and Os(II) (4)], where tpy-PhCH(3) = p-methylphenyl terpyridine, H(2)pbbzim = 2,6-bis(benzimidazole-2-yl)pyridine and tpy-HImzPh(3) = 4'-[4-(4,5-diphenyl-1H-imidazol-2-yl)-phenyl]-[2,2':6',2'']terpyridine, have been synthesized and characterized by using standard analytical and spectroscopic techniques. These compounds were designed to increase the room temperature excited-state lifetimes of bisterpyridine-type ruthenium(II) and osmium(II) complexes. The X-ray crystal structures of two homoleptic complexes 3 and 4 have been determined and show that both the compounds crystallized in orthorhombic form with space group Fddd. The photophysical and redox properties of the complexes have been thoroughly investigated. All the complexes display moderately strong luminescence at room temperature with lifetimes in the range of 6-35 ns. The complexes are found to undergo one reversible oxidation in the positive potential window (0 to +1.6 V) and one irreversible and two successive quasi-reversible reductions in the negative potential window (0 to -2.0 V). The influence of solvents on the photophysical properties of the complexes has also been investigated in detail.

Download full-text PDF

Source
http://dx.doi.org/10.1039/c1dt11645bDOI Listing

Publication Analysis

Top Keywords

rutheniumii osmiumii
12
osmiumii complexes
12
bis-tridentate rutheniumii
8
complexes
8
room temperature
8
properties complexes
8
potential window
8
luminescent bis-tridentate
4
complexes based
4
based terpyridyl-imidazole
4

Similar Publications

Chemotherapeutic Activities of New η--Cymene Ruthenium(II) and Osmium(II) Complexes with Chelating SS and Tridentate SNS Ligands.

Molecules

February 2024

Nano-Gene and Drug Delivery Group, Discipline of Biochemistry, School of Life Sciences, College of Agriculture, Engineering and Science, University of KwaZulu-Natal, Private Bag X54001, Durban 4000, South Africa.

A series of new chelating bidentate (SS) alkylimidazole-2-thione-Ru(II)/Os(II) complexes (, , , /, , ), and the tridentate (SNS) pyridine-2,6-diylimidazole-2-thione-Ru(II)/Os(II) complexes (, /, , ) in the forms [M(cym)(L)Cl]PF and [M(cym)(L)]PF (M = Ru or Os, cym = η--cymene, and L = heterocyclic derivatives of thiourea) respectively, were successfully synthesized. Spectroscopic and analytical methods were used to characterize the complexes and their ligands. Solid-state single-crystal X-ray diffraction analyses revealed a "piano-stool" geometry around the Ru(II) or Os(II) centers in the respective complexes.

View Article and Find Full Text PDF

Investigating the anticancer potential of 4-phenylthiazole derived Ru(II) and Os(II) metalacycles.

Dalton Trans

March 2024

Institute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Waehringer Straße 42, 1090 Vienna, Austria.

In this contribution we report the synthesis, characterization and anticancer activity of novel cyclometalated 4-phenylthiazole-derived ruthenium(II) (2a-e) and osmium(II) (3a-e) complexes. Formation and sufficient purity of the complexes were unambigiously confirmed by H-, C- and 2D-NMR techniques, X-ray diffractometry, HRMS and elemental analysis. The binding preferences of these cyclometalates to selected amino acids and to DNA models including G-quadruplex structures were analyzed.

View Article and Find Full Text PDF

Herein, we disclose a unique method of oxidation of a 1,4-naphthoquinone ring in air. We report that (1,4-naphthoquinone)-NH-N=C(OH)Ph (HL) coordinated to octahedral ruthenium(II) and osmium(II) ions activates an O molecule spontaneously. Hydrogen atom transfer (HAT) from the -NH- function of HL to O and subsequent (2e + 2H) oxidation forming (1,3,4-trioxonaphthalen)=N-N=C(OH)Ph (HL) have been established.

View Article and Find Full Text PDF

Systematic investigations on the reactions between cis-[M(dppm) Cl ] (M=Ru/Os; dppm=1,1-bis(diphenylphosphino)methane) and pyridine/quinoline substituted homopropargylic alcohols uncovered the diverse Ru(II)/Os(II)-induced alkyne activation pathways. The alkynes underwent cyclization on M via a "non-vinylidene" pathway at lower temperatures, resulting in alkenyl intermediates which might further metallacyclize to give metallapyrroloindolizines. Conversely, reactions at higher temperatures induced alkyne cyclization on M via a "vinylidene" pathway, affording cyclic oxacarbene complexes.

View Article and Find Full Text PDF

The search for new scaffolds of medicinal significance combined with molecular shape enhances their innovative potential and continues to attract the attention of researchers. Herein, we report the synthesis, spectroscopic characterization (H and C NMR, UV-vis, IR), ESI-mass spectrometry, and single-crystal X-ray diffraction analysis of a new ring system of medicinal significance, 5,6,7,9-tetrahydro-8-indolo[3,2-]benzazocin-8-one, and a series of derived potential ligands (), as well as ruthenium(II), osmium(II), and copper(II) complexes (, , and ). The stability of compounds in 1% DMSO aqueous solutions has been confirmed by H NMR and UV-vis spectroscopy measurements.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!